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Abstract – The objective of this clinical trial was to examine the effect of a single dose of florfenicol
on antimicrobial resistance patterns in faecal E. coli of feedlot steers. Steers (n = 370), were
purchased from two sources and housed in outdoor concrete floored pens. Two cattle from each pen
(n = 42 pens, 84 cattle) were randomly selected for faecal sampling at study day 1, 14, 28, and 42.
One sampled animal from each of 21 pens was randomly selected to receive a single 39.6 mg/kg
dose of florfenicol subcutaneously at study day 11. Ten lactose positive colonies were isolated from
faecal swabs and tested for antimicrobial resistance to 11 antimicrobials using the disk diffusion
method. Zones of inhibition were grouped using cluster analysis and clusters were ordered by
increasing multiple resistance. A cumulative logistic regression model using generalized estimating
equations was used to assess factors associated with increasing levels of multiple resistance.
Immediately post-treatment, all isolates obtained from treated cattle belonged to multiple resistant
clusters containing chloramphenicol resistance. Though less pronounced in later sampling,
resistance to chloramphenicol and other antimicrobials persisted. Antimicrobial treatment,
sampling time and animal source, as well as interactions between these variables, were important
predictors of the odds of E. coli belonging to a more resistant cluster. A very clear but transitory
shift to increasingly multiple resistant faecal E. coli in response to florfenicol treatment was
observed. There was no indication of horizontal transfer of resistant E. coli between steers. Level of
resistance was influenced by complex interaction of animal source and previous management.
antimicrobial resistance / food animal / florfenicol / Escherichia coli
1. INTRODUCTION
There has been ongoing debate concern-
ing the effect of therapeutic and non-thera-
peutic veterinary antimicrobials on human
health [25, 28]. Animal agriculture has been
implicated as a major user of antimicrobi-
als, and, by extension, a major contributor
to antimicrobial resistance. Traditionally,
antimicrobial resistance was studied through
* Corresponding author: Epperson.1@osu.edu
Article published by EDP Sciences and available at http://www.edpsciences.org/vetres or http://dx.doi.org/10.1051/vetres:2005027
724 A.C.B. Berge et al.
use of a specific organism, and through
monitoring antimicrobial resistance in that
organism over time [26]. Often these spe-
cific organisms were pathogens, and inten-
sive study allowed identification of emerg-
ing trends, estimation of prevalence in
animals or animal products, and investiga-
tion of antimicrobial resistance mecha-
nisms. However, for population assess-
ment, use of a pathogenic organism may be
problematic since prevalence may be low
[24]. The objective of population monitor-
ing may be more toward determining pre-
dominate antimicrobial resistance, rather
than documenting low prevalence antimi-
crobial resistance.
Antimicrobial resistance assessment of
commensal organisms has been used to
study gastrointestinal tract ecology and
track environmental organisms to a pre-
sumed source [14, 16, 23]. Commensal E.
coli have been used as a monitor of antimi-
crobial resistance in cattle and swine pop-
ulations [5, 10, 30, 31]. Use of commensal
organisms is convenient and allows meas-
urement of the resistance gene pool that
may be transmitted to pathogenic bacteria.
Several studies have indicated that inter-
species resistance transfer occur in bacteria,
and increased recovery of antimicrobial
resistant faecal E. coli was seen in dairy
farms affected with resistant salmonellosis
[6, 8, 11]. The level of resistance in com-
mensal enteric bacteria has been correlated
with resistance in pathogenic bacteria [11]. 
In cattle, factors apart from antimicrobial
administration affect antimicrobial resist-
ance, including age, environment, and nutri-
tion [9, 16–18]. Long-term use of antimi-
crobials may select for antimicrobial
resistance that persists over time, though
duration of antimicrobial resistance in fae-
cal E. coli in feedlot cattle following thera-
peutic antimicrobial usage appears to be
short [20, 29]. 
Florfenicol is a veterinary fluorinated
analogue of tiamphenicol approved in 1996
in the United States for bovine respiratory
disease pathogens [13]. Florfenicol is a bac-
teriostatic antimicrobial with similar mode
of action to chloramphenicol, binding to the
50S subunit of bacterial ribosomes. The flo
gene confers resistance to chloramphenicol
and florfenicol, and is most commonly
located on a large transferable plasmid in
bovine enteric E. coli [27, 33].
The objective of this study was to exam-
ine the effect of a single therapeutic dose of
florfenicol on antimicrobial susceptibility
patterns in faecal E. coli of steers within one
month post treatment.
2. MATERIALS AND METHODS
2.1. Animal sampling and treatment
The clinical trial was performed on ani-
mals included in nutrition experiments at
the South Dakota State University Rumi-
nant Nutrition Research Center in the
autumn of 2001. Angus and Angus cross-
bred steers (n = 370), weighing approxi-
mately 270 kg were purchased directly from
source A (n = 196) and B (n = 174) and
arrived on October 25 and October 31, 2001
respectively. Calves and dams were rounded
up on the range and steer calves were
weaned and shipped directly from the
ranch. Sixty steers from source B had been
weaned and held in a dirt lot for approxi-
mately one month prior to shipment to the
research center. Cattle were used in two
nutrition experiments, apart from the study
here. Source A steers were assigned to one
of two treatments in a study involving die-
tary trace mineral inclusion rate. Source B
steers were placed into one of four treat-
ments to study effect of various grain by-
products on health and performance. Cattle
were housed in 42 open concrete floor pens
(8–10 head/pen). Prior to the study, pens
had been scraped free of physical debris and
were unoccupied for 30 days. The iono-
phore monensin (Rumensin, Elanco Ani-
mal Health, Indianapolis, Indiana, USA),
was incorporated into the diet at a rate of
20 grams/ton of feed, and was the only
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antimicrobial in feed or water. Two cattle
from each pen (n = 84) were randomly
enrolled into the study. Serial rectal faecal
samples were obtained using cotton tipped
swabs from all study animals on days 1, 14,
28, and 42. At study day 11, one study ani-
mal from half the pens (n = 21) was ran-
domly selected to receive a single 39.6 mg/
kg dose of florfenicol (Nuflor – Schering-
Plough Animal Health, Kenilworth, New
Jersey, USA) by subcutaneous injection. The
use of this treatment regime was within label
indications. Animals selected for antimi-
crobial treatment came from both source A
(n = 12, 25% of cattle) and source B (n = 9,
25% of cattle). A total of 48 steers in 24 pens
from source A and 36 steers in 18 pens from
source B were sampled.
2.2. Sampling and isolation of E. coli 
Swabs were plated onto MacConkey
agar within 3 h of acquisition and incubated
24 h at 35 ºC. Ten well isolated lactose pos-
itive colonies (or as many that were present,
if less than 10) were randomly selected from
each plate for antimicrobial resistance test-
ing. Biochemical confirmation was per-
formed on 49 randomly selected isolates
using triple sugar iron agar (TSI), motility,
and indole media.
Antimicrobial susceptibility tests were
performed using the disk diffusion assay [4].
The selected colonies were inoculated into
NaCl sterile solution (0.85%) to achieve an
optical density corresponding to 0.5 McFar-
land units. A sterile swab was dipped into
the adjusted suspension and streaked onto
Mueller-Hinton (MH) agar plates (150 ×
15 mm) to form a uniform lawn of bacterial
growth. Eleven drug-impregnated disks
were placed on the surface of the agar using
a disk dispenser (Tab. I). The plates were
incubated at 37 ºC for 16 to 18 h and zones
of inhibition around each disc measured to
the nearest mm. The quality control strain
E. coli ATCC 25922 (ATTC, Manassas,
Virginia, USA) was used for each batch of
isolates tested [1].
2.3. Quantitative analysis
Data from E. coli antibiograms were a
series of continuous measurements repre-
senting inhibition zone size to each of 11 anti-
microbials. Descriptive statistics were cal-
culated on isolates to determine the zone
Table I. Antimicrobials and concentrations used for susceptibility testing of faecal E. coli isolates
using the disk diffusion method.
Antimicrobial Code Concentration (µg)
Amoxicillin/clavulanic acid AMC 20/10
Ampicillin AMP 10
Cephalothin CEF 30
Chloramphenicol CHL 30
Gentamicin GEN 10
Nalidixic acid NAL 30
Spectinomycin SPT 100
Streptomycin STR 10
Sulfisoxazole SULF 250
Tetracycline TET 30
Sulfamethoxazole/trimethoprim SXT 23.75/1.25
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size distribution for each antimicrobial.
Antimicrobials with a bimodal distribution
of inhibition zones were used in grouping
the strains using cluster analysis. Clusters
were determined using Ward’s minimum
variance method and squared Euclidean
distance, as described [5, 12, 32]. Clusters
were considered ordinal outcomes, and
ordered according to increasing resistance,
based on a decreasing sum of mean inhibi-
tion zone sizes to the eleven antimicrobials.
The statistical software package SAS ver-
sion 8 (SAS Institute, Cary, North Carolina,
USA) was used for data analysis. 
Contingency tables of effects of source
(A or B), sampling (1, 2, 3 or 4), and flor-
fenicol treatment on E. coli antimicrobial
cluster membership were developed. The
effect of florfenicol treatment on the distri-
bution of chloramphenicol resistance was
evaluated with the Chi-square statistic. The
Wilcoxon-Mann-Whitney test was used to
determine differences in resistance between
source groups. A comparison of antimicro-
bial resistance clusters between steers being
housed in the same pen as treated steers and
those steers in pens without any treated
steers was performed using stratified anal-
ysis, and post-antibiotic treatment cluster
distribution was tested using the Wilcoxon-
Mann-Whitney test. 
A mixed effects cumulative logistic
regression model using generalized esti-
mating equations was developed, using
cluster membership as the outcome of inter-
est [3, 19]. The model predicted the odds of
the E. coli belonging to a more resistant
cluster, given a set of explanatory variables
including source (“source”, consisting of
two categories [A or B]), early weaning
(termed “wean”, consisting of two catego-
ries to account for steers from source B that
were weaned one month prior to shipment
and other), sampling time (“time”, 1–4),
Table II. Antimicrobial susceptibility clusters of faecal E. coli isolates (total number = 3145) in a
trial evaluating single-dose florfenicol treatment of steers. Mean disk diffusion zone (mm) is given
for each cluster-antimicrobial combination, as well as number of isolates (Frequency) in each
cluster*.
Cluster Frequency AMC AMP CEF CHL GEN NAL SPT STR SXT SULF TET
A 2518 25 23 22 25 23 27 24 18 31 25 26
B 263 25 23 22 25 23 26 24 17 30 25 11
C 23 22 6 21 26 23 27 25 18 31 24 6
D 5 27 26 24 6 22 29 23 6 31 24 6
E 54 24 22 21 25 23 27 24 11 24 6 6
F 31 25 23 22 26 23 28 15 12 26 6 6
G 71 26 24 22 6 23 26 23 6 22 6 7
H 12 23 6 21 26 22 28 15 9 25 6 6
I 12 20 6 20 6 24 26 24 7 21 6 6
J 8 20 6 20 6 22 29 16 6 6 6 6
K 31 11 6 6 6 23 27 25 6 19 6 6
L 107 13 6 6 6 23 28 15 6 23 6 7
M 10 16 6 12 6 12 28 6 6 21 6 6
* Zone sizes in dark shading indicate resistance to the antimicrobial and zone sizes in light shading
indicate intermediate resistance, according to National Committee for Clinical Laboratory Standards
(NCCLS) guidelines for human E. coli. Zone sizes without shading indicate sensitivity according to
same standard.
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florfenicol treatment (“abtx”, yes/no cate-
gorical), pen mate to treated steer (yes/no cat-
egorical), and nutrition treatment (two cate-
gories). Second and third order interactions
were included in the model. A stepwise for-
ward selection procedure was used in a pop-
ulation average model for variable selec-
tion. Since a large number of observations
were available, a p value of ≤ 0.1 was used
for entry and retention in the model. The
variables that were retained in the popula-
tion average model were thereafter intro-
duced into a model using generalized esti-
mating equations (GEE) to control for
multiple isolates from each faecal sample
[15]. This was performed with a repeated
measure on calf at each sampling occasion
with an independent correlation matrix
design. The proportional odds assumption
was assessed by the score statistic and by
graphing odds ratios for sampling and treat-
ment group at each level in the cluster hier-
archy and assessing trends. The final model
was described by the following equation:
Logit(cluster) = β0 + β1 (abtx) + β2(source) + β3 (wean) + β4 (time) + β5(abtx × time) + β6 (source × time) + β7(abtx × source)/(repeated sampling within
calf × time).
3. RESULTS
3.1. Overview
During the study, no animal in the sam-
pling cohort became ill or necessitated anti-
microbial treatment. Of the total 370 cattle
received, only 1 animal (not sampled in this
study) required treatment for illness between
arrival and study end. 
In total, 3179 isolates were obtained
from the steers. Of the 49 isolates biochem-
ically tested, 48 (98%) produced reactions
typical of E. coli. The inhibition zones for
most antimicrobials demonstrated a bimo-
dal distribution. All isolates were sensitive
to nalidixic acid. Since antimicrobial sus-
ceptibility tests to nalidixic acid exhibited
no bimodal distribution, they were not
included as variables to determine antimi-
crobial resistance cluster membership, but
are included in description of clusters. 
3.2. Antimicrobial resistance clusters 
The E. coli antimicrobial resistance clus-
ter characteristics and number of isolates
belonging to each cluster are shown in
Table II. Clusters were optimized to contain
minimal intra-cluster variability to the
eleven antimicrobials. The optimal number
of clusters was based upon having isolates
with disk diffusion zones only in one zone
of the bimodal distribution. Thirteen clus-
ters adequately described the major antimi-
crobial resistance patterns and were ordered
in increasing levels of resistance from A to
M. Of the 3179 isolates, 34 (about 1% of the
dataset) were trimmed during the clustering
algorithm, leaving 3145 isolates for analy-
sis. The majority of isolates (82%) belonged
to cluster A, containing bacteria susceptible
to the 11 antimicrobials. Tetracycline resist-
ance was seen in the remaining clusters (B–
M) combined with other resistance to one
or several antimicrobials. Chloramphenicol
resistance, which is present in E. coli when
florfenicol resistance is present, was seen in
cluster D, G and I–M.
3.3. Statistical analysis
A contingency table of E. coli cluster
membership by sampling time and source is
shown (Tab. III). The influence of florfen-
icol treatment on E. coli cluster membership
was assessed (Tab. IV). Treated steers dis-
played a significantly greater proportion of
isolates with chloramphenicol resistance
than non-treated steers at sampling days 14,
28 and 42. On the second sampling, occur-
ring 3 days post-treatment (day 14), all iso-
lates obtained from treated cattle belonged
to clusters containing chloramphenicol resist-
ance, compared to only 1% of isolates from
non-treated steers. Though less pronounced
in the third and fourth sampling, treated cat-
tle had significantly greater proportion of
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isolates belonging to clusters with chloram-
phenicol resistance. Apart from the 1% of
isolates belonging to chloramphenicol resist-
ant cluster D found at Day 14, there was no
indication of chloramphenicol resistance in
control steers. The faecal E. coli isolates
obtained from non-treated steers housed in
pens with treated steers compared to non-
treated steers housed in pens with only non-
treated steers revealed no significant differ-
ence in cluster distribution (Wilcoxon-
Mann-Whitney test p-value = 0.46)
The multinomial logistic regression
model showed that treatment group, sam-
pling time and animal source, as well as
interactions between these variables, were
important predictors of the odds of E. coli
belonging to a more resistant cluster
(Tab. V). There was no association with
nutrition treatment and pen mates to treated
steers did not show increasing levels of
resistance compared to steers in pens with-
out treatment. 
The main effect of treatment indicates a
clear shift toward carriage of more resistant
E. coli in calves treated with florfenicol.
The statistical interactions indicate an
effect-measure modification. In order to
determine the probability of a steer belong-
ing to a higher order cluster, the log-odds of
all variables, main effects and interactions,
must be calculated. As a result, the GEE
estimate of log odds ratio associated with
single main effect variables cannot be sim-
ply interpreted as the magnitude of effect.
The model is therefore discussed in terms
of trends for different variables. Abtx × time
interaction formally indicated what was
Table III. Percentage of faecal E. coli isolates (total number = 3145) by source group (A and B), sam-
pling occasion (day 1, 14, 28 and 42), and antimicrobial resistance cluster membership in a trial eval-
uating single-dose florfenicol treatment of steers.
Cluster Frequency
Percentage of E. coli isolates by source, sampling, and cluster membership
Day 1* Day 14** Day 28** Day 42**
A B A B A B A B
A 2518 97 76 73 64 85 81 88 87
B 263 3 6 2 5 6 13 6 10
C 23 0 3 0 0 2 0 0 0
D 5 0 0 1 0 0 0 0 0
E 54 0 6 0 3 0 2 1 1
F 31 0 5 0 2 0 2 0 0
G 71 0 0 3 7 4 2 2 1
H 12 0 3 0 0 0 0 0 1
I 12 0 0 0 3 0 0 0 0
J 8 0 0 0 2 2 0 0 0
K 31 0 0 17 5 0 0 3 0
L 107 0 0 1 7 0 0 0 0
M 10 0 0 2 1 0 0 0 0
* Source group B had significantly higher proportion of isolates belonging to more resistant clusters than
group A (Wilcoxon-Mann-Whitney test, p-value < 0.0001).
** No significant difference in resistance between group A and B at day 14, 28 and 42, Wilcoxon-Mann-
Whitney test p-value = 0.16, 0.23 and 0.46 respectively.
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evident in the contingency tables, that E.
coli isolates of treated calves tended to
return to less resistant cluster groupings as
time from treatment increased.
Calves from source B tended to carry a
greater proportion of resistant E. coli than
calves from source A. Furthermore, calves
from source B that were weaned one month
prior to shipment carried a higher propor-
tion of resistant E. coli compared to calves
gathered up directly from pasture. 
Over time, E. coli antimicrobial resist-
ance between sources moved toward a com-
mon profile. Though source A steers dis-
played a greater proportion of susceptible E.
coli initially, time × source interaction indi-
cated that source A tended to display more
resistance over time, relative to source B
steers. Furthermore, abtx × source interac-
tion indicates source A calves tended to
carry a greater proportion of resistant E. coli
due to treatment than calves from source B. 
4. DISCUSSION
Florfenicol is a fluorinated analogue of
chloramphenicol that was approved in 1996
in the USA for bovine respiratory disease
pathogens. It is routinely used in the USA
feedlot industry and has been shown to be
clinically successful in treating respiratory
disease and fever [4]. It has broad spectrum
activity, including respiratory pathogens
and gram-negative bacterial flora, and has
an extended duration of action. It is found
in high concentration in urine and bile, and
would be expected to impact faecal E. coli
flora [2]. Chloramphenicol, the parent
Table IV. Percentage faecal E. coli isolates (total number = 3145) belonging to antimicrobial resist-
ance clusters A–M from steers in a clinical trial having received a single-dose florfenicol treatment
on study day 11 (abtx) group and control group by sampling occasion (day 1, 14, 28 and 42).
Cluster Frequency
Percentage of E. coli isolates by treatment group, sampling time, 
and cluster membership
Day 1 Day 14* Day 28* Day 42*
control abtx control abtx control abtx control abtx
A 2518 88 87 91 0 87 72 88 83
B 263 5 5 5 0 10 8 9 5
C 23 2 0 0 0 2 0 0 0
D** 5 0 0 1 0 0 0 0 0
E 54 3 3 2 0 1 2 2 1
F 31 3 0 1 0 1 0 0 0
G** 71 0 0 0 20 0 12 0 6
H 12 0 4 0 0 0 0 1 0
I** 12 0 0 0 7 0 0 0 0
J** 8 0 0 0 4 0 0 0 0
K** 31 0 0 0 17 0 1 0 0
L** 107 0 0 0 47 0 6 0 6
M** 10 0 0 0 6 0 0 0 0
* Steers receiving florfenicol treatment on day 11 had a significantly greater proportion of isolates
belonging to clusters with chloramphenicol resistance than non-treated steers (Chi-square p-value <
0.05).
** Clusters containing chloramphenicol resistance.
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Table V. Cumulative logistic model: GEE Estimates of log odds faecal E. coli isolates belonging to
clusters with higher level antimicrobial resistance in a trial evaluating single-dose florfenicol treat-
ment of steers on antimicrobial resistance in faecal E. coli.
GEE
estimate
Standard 
error Df 
Lower
C.I.
Upper
C.I.
Chi-
square P-value
Treatment (abtx)
No Reference
Yes 6.34 0.66 1 5.05 7.63 9.64 < 0.0001
Sampling time (time)
1 Reference
2 –0.80 0.39 1 –1.57 –0.03 –2.03 0.0427
3 –0.52 0.40 1 –1.31 0.27 –1.29 0.1962
4 –0.76 0.39 1 –1.53 0.01 –1.93 0.0542
Source of steers (source)
B Reference
A –2.07 0.41 1 –2.87 –1.28 –5.1 < 0.0001
Weaned one month prior shipment (wean)
Yes Reference
No –0.59 0.29 1 –1.16 –0.02 –2.04 0.0416
Interaction time and source
Time = 4 Source A 1.88 0.53 1 0.83 2.92 3.52 0.0004
Time = 4 Source B Reference
Time = 3 Source A 1.69 0.57 1 0.57 2.80 2.96 0.003
Time = 3 Source B Reference
Time = 2 Source A 1.30 0.62 1 0.09 2.51 2.1 0.0357
Time = 2 Source B Reference
Time = 1 Source A Reference
Time = 1 Source B Reference
Interaction abtx and source
abtx = 1 Source A 1.31 0.48 1 0.36 2.25 2.72 0.0065
abtx = 1 Source B Reference
abtx = 0 Source A Reference
abtx = 0 Source B Reference
Interaction abtx and time
abtx = yes Time = 4 –6.51 0.85 1 –8.17 –4.84 –7.66 < 0.0001
abtx = yes Time = 3 –5.89 0.75 1 –7.36 –4.43 –7.9 < 0.0001
abtx = yes Time = 2 Reference
abtx = no Time = 4 Reference
abtx = no Time = 3 Reference
abtx = no Time = 2 Reference
abtx = no Time = 1 Reference
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compound of florfenicol, was prohibited
from use in food animals in 1986. 
This study has demonstrated a very clear
but transitory shift in antimicrobial resist-
ance patterns of faecal E. coli of feedlot
steers in response to systemic florfenicol
treatment. Results here indicate that flor-
fenicol selects for exclusively resistant fae-
cal flora three days post treatment, during
the period when the antimicrobial would be
expected to be present in the feces. This sug-
gests that post-therapy, treated animals
shed a larger proportion of resistant organ-
isms in their faeces. 
Treated steers had a significantly higher
proportion of isolates belonging to clusters
with chloramphenicol resistance, compared
to non-treated steers. We hypothesize that
this is due to selection of E. coli with a plas-
mid or chromosomally located flo gene con-
ferring resistance to florfenicol and chlo-
ramphenicol [27, 33]. Additionally, florfenicol
treatment selected for E. coli isolates that
exhibited simultaneous resistance to several
other antimicrobial classes. We hypothesize
that this resistance co-selection is due to
linkage of antimicrobial resistance genes.
E. coli have been shown to harbour a large
array of plasmids with different antimicro-
bial resistance genes. Florfenicol treatment
likely selected for E. coli with plasmids con-
taining multiple antimicrobial resistance
genes. Several plasmid types carrying the
flo gene in E. coli isolates of bovine origin
have been identified, and multiple resist-
ance was a common feature [7].
Whether multi-resistant E. coli persist in
the environment, or establish in non-treated
animals following casual contact is not
known. The 21 untreated pen mates of
treated cattle showed no tendency to shed
faecal E. coli with higher levels of resist-
ance. This finding suggested that the envi-
ronmental spread of resistant bacteria from
treated to untreated steers was limited in this
study. 
Due to limited resources, we did not
confirm all isolates as E. coli, so a small pro-
portion of non-E. coli organisms almost cer-
tainly were included in the analysis. Assum-
ing they occurred sporadically and at random,
they would not be expected to affect the
analysis. Berge et al. demonstrated no dif-
ference in antimicrobial resistance pattern
distribution in non-E. coli isolated from
MacConkey agar compared to isolates bio-
chemically confirmed as E. coli [5]. 
Our study has shown that the antimicro-
bial resistance associated with florfenicol
treatment decreased dramatically over
4 weeks post-treatment. Similar to other
range beef populations, this population of
steers had generally susceptible flora at
sample day 1. It appears that antimicrobial
treatment as described here did not have a
large long-term effect on E. coli resistance
pattern of treated cattle. By study end, some
resistant organisms were evident in treated
steers, compared to controls. The signifi-
cance of this small proportion, about 6% of
E. coli, is unknown. It is unknown what
effect another antimicrobial treatment, flor-
fenicol or other, would have in treated
steers.
Use of cluster analysis allowed descrip-
tive assessment of antimicrobial suscepti-
bility to multiple antimicrobials. As a result
of florfenicol treatment, resistance to chlo-
ramphenicol was observed, as well as resist-
ance to other antimicrobials. Higher order
clusters were associated with higher orders
of resistance, and florfenicol treatment was
associated with selection of E. coli possess-
ing chloramphenicol, tetracycline, sulfisox-
azole, streptomycin, and some beta-lactam
resistance. It is unknown if the resistance
observed was transferable, so it is not pos-
sible to fully assess the direct implication of
this observation. 
As indicated by the stratified analysis
and multinomial model, antibiotic treat-
ment had a strong effect on E. coli antimi-
crobial resistance patterns. However, the
model and stratified analysis both indicated
that E. coli antimicrobial resistance patterns
in treated steers moved back toward base-
line levels over time. Resistant bacteria may
incur a fitness cost to retain resistance genes
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in the absence of further antibiotic selective
pressure [21]. At the end of our study a
higher proportion of faecal E. coli were
resistant than at the time of arrival. It is
unknown whether this proportion would
further decrease over time, or stabilize at
this level.
Though of lesser magnitude, environ-
mental factors influenced level of antimi-
crobial resistance following treatment.
Source differences are intriguing, in that
they suggest some attribute or dynamic that
existed at arrival and impacted subsequent
antimicrobial resistance cluster member-
ship. Though individual antimicrobial use
records were not available from ranch
sources, antimicrobials were not included
in feed prior to feedlot entry. Additionally,
ranch personnel indicated that use of anti-
microbials for individual animal treatment
was very infrequent. The difference between
source A and source B was not solely attrib-
uted to the fact that some calves were
weaned and rounded up one month prior
shipment, but that other environmental fac-
tors were also involved. It is unknown how
these effects would appear after a longer
time in the feedlot.
Though E. coli of source A steers
appeared more susceptible initially, they
paradoxically tended to shift to higher lev-
els of resistance with time, compared to
source B. In a similar manner, swine not
exposed to antimicrobials as piglets, then
exposed subsequently showed a similar
response, compared to swine exposed to
antimicrobials early in life [10]. Initial anti-
microbial susceptibility differences observed
between sources decreased over time in the
feedlot, as proportions of isolates in source A
and source B calves appeared to become
similar. Changes observed over time between
sources reflect a natural selection toward a
uniform flora. This flora is apparently influ-
enced by factors apart from antimicrobial
use, possibly including feedstuffs, feed
management, and pen environment [9, 16,
20]. This observation has ramifications in
future studies, and suggests that source may
impact faecal E. coli resistance patterns, but
that these patterns will tend to migrate
toward the patterns dictated by feedlot envi-
ronment. This suggests that antimicrobial
resistance of feedlot cattle may be partially
manipulated by management interventions
apart from controlling antimicrobial use in
the feedlot, and may suggest that antimicro-
bial resistance of enteric bacteria in animals
not exposed to antimicrobials may still
exhibit changes over time [22]. 
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